Yahoo Web Search

Search results

    • Q1 2024 Sarepta Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 hours ago

      Before I begin, let me provide you with an update. As you know, we have submitted a BLA supplement to expand the labeled population for our Duchenne gene therapy ELEVIDYS.